{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:31:23Z","timestamp":1790915483560,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1097\/01.sla.0000146145.69835.c5","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T04:01:13Z","timestamp":1101355273000},"page":"1027-1036","source":"Crossref","is-referenced-by-count":277,"title":["Does the Novel PET\/CT Imaging Modality Impact on the Treatment of Patients With Metastatic Colorectal Cancer of the Liver?"],"prefix":"10.1097","volume":"240","author":[{"given":"Markus","family":"Selzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Hany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Wildbrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakiyah","family":"Kadry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alain","family":"Clavien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","article-title":"Cancer statistics.","volume":"47","author":"Parker","year":"1997","journal-title":"Cancer J Clin"},{"key":"R2-12-20210203","first-page":"137","article-title":"Malignant Liver Tumors: Current and Emerging Therapies.","author":"Selzner","year":"1999"},{"key":"R3-12-20210203","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1072-7515(00)00261-1","article-title":"Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection.","volume":"191","author":"Belghiti","year":"2000","journal-title":"J Am Coll Surg"},{"key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/01.sla.0000098620.27623.7d","article-title":"A prospective randomized study in 100 consecutive patients undergoing major liver resection with vs. without ischemic preconditioning.","volume":"238","author":"Clavien","year":"2003","journal-title":"Ann Surg"},{"key":"R5-12-20210203","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00000658-200004000-00005","article-title":"Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.","volume":"231","author":"Azoulay","year":"2000","journal-title":"Ann Surg"},{"key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/msy.2002.122374","article-title":"Downstaging of hepatocellular carcinoma and metastasis from colorectal cancer by selective intra arterial chemotherapy.","volume":"131","author":"Clavien","year":"2002","journal-title":"Surgery"},{"key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000658-199610000-00009","article-title":"Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.","volume":"224","author":"Bismuth","year":"1996","journal-title":"Ann Surg"},{"key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/lt.500030611","article-title":"Vascular occlusion in hepatic resections in cirrhotic rat livers: an experimental study in rats.","volume":"3","author":"Figueras","year":"1997","journal-title":"Liver Transplant Surg"},{"key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0039-6109(05)70531-4","article-title":"Invasive therapy of metastatic colorectal cancer to the liver.","volume":"77","author":"Millikan","year":"1997","journal-title":"Surg Clin North Am"},{"key":"R11-12-20210203","first-page":"13","article-title":"Indicators of prognosis after hepatic resection for colorectal secondaries.","volume":"110","author":"Scheele","year":"1991","journal-title":"Surgery"},{"key":"R12-12-20210203","article-title":"On the Metabolism of Tumors in the Body.","author":"Warburg","year":"1930"},{"key":"R13-12-20210203","first-page":"670","article-title":"A fluorinated glucose analoge, 2-fluoro-2-deoxy-D-glucose (F18): nontoxic tracer for rapid tumor detection.","volume":"21","author":"Som","year":"1980","journal-title":"J Nucl Med"},{"key":"R14-12-20210203","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(94)90753-6","article-title":"Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer.","volume":"344","author":"Lewis","year":"1994","journal-title":"Lancet"},{"key":"R15-12-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1078-5337(02)00085-0","article-title":"Positron emission tomography scanning in lung cancer.","volume":"9","author":"Lowe","year":"2003","journal-title":"Resp Care Clin North Am"},{"key":"R16-12-20210203","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMoa022136","article-title":"Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.","volume":"348","author":"Lardinois","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-12-20210203","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.0007-1323.2002.02059.x","article-title":"Positron emission tomography for staging and management of malignant melanoma.","volume":"89","author":"Prichard","year":"2002","journal-title":"Br J Surg"},{"key":"R18-12-20210203","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/archsurg.1996.01430190025007","article-title":"The role of whole-body positron emission tomography with [18]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.","volume":"131","author":"Lai","year":"1996","journal-title":"Arch Surg"},{"key":"R19-12-20210203","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1245\/ASO.2003.05.006","article-title":"Positron emission tomography affects surgical management in recurrent colorectal cancer patients.","volume":"10","author":"Desai","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R20-12-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/ejso.2000.1075","article-title":"Clinical value of whole-body positron emission tomography in potentially curable colorectal liver metastases.","volume":"27","author":"Topal","year":"2001","journal-title":"EJSO"},{"key":"R21-12-20210203","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.sla.0000138076.72547.b1","article-title":"Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose.","volume":"240","author":"Fernandez","year":"2004","journal-title":"Ann Surg"},{"key":"R22-12-20210203","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/radiol.2252011568","article-title":"PET diagnostic accuracy: improvement with in-line PET-CT system: Initial results.","volume":"225","author":"Hany","year":"2002","journal-title":"Radiology"},{"key":"R23-12-20210203","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00259-001-0698-9","article-title":"CT vs 68Ge attenuation correction in a combined PET\/CT system: evaluation of the effect of lowering the CT tube current.","volume":"29","author":"Kamel","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R24-12-20210203","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1200\/JCO.1996.14.3.700","article-title":"Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.","volume":"14","author":"Findlay","year":"1996","journal-title":"J Clin Oncol"},{"key":"R25-12-20210203","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1200\/JCO.2002.20.2.388","article-title":"Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.","volume":"20","author":"Ruers","year":"2002","journal-title":"J Clin Oncol"},{"key":"R26-12-20210203","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0748-7983(95)97046-0","article-title":"Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging.","volume":"21","author":"Schiepers","year":"1995","journal-title":"Eur J Surg Oncol"},{"key":"R27-12-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9610(99)80067-1","article-title":"Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.","volume":"171","author":"Vitola","year":"1996","journal-title":"Am J Surg"},{"key":"R28-12-20210203","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02234732","article-title":"Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer.","volume":"44","author":"Johnson","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"R29-12-20210203","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/bjs.1800811136","article-title":"Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.","volume":"81","author":"Beets","year":"1994","journal-title":"Br J Surg"},{"key":"R30-12-20210203","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9610(99)00187-7","article-title":"Utility of [18]F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.","volume":"178","author":"Fong","year":"1999","journal-title":"Am J Surg"},{"key":"R31-12-20210203","first-page":"1797","article-title":"Direct comparison of (18)F-FDG PET and PET\/CT in patients with colorectal carcinoma.","volume":"44","author":"Cohade","year":"2003","journal-title":"J Nucl Med"},{"key":"R32-12-20210203","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF02557264","article-title":"Significance of hepatic lymphe node involvement in patients with colorectal liver metastases: a prospective study.","volume":"9","author":"Jaeck","year":"2002","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.sla.0000146145.69835.c5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:39:43Z","timestamp":1785850783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-200412000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.sla.0000146145.69835.c5","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}